Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
145.7 USD | -0.78% | -2.60% | -7.06% |
Apr. 29 | J&J, Bristol Myers lose challenges to US drug price negotiation program | RE |
Apr. 29 | J&J: positive CHMP opinion for lung cancer | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.06% | 354B | |
+33.72% | 664B | |
+27.98% | 567B | |
+19.23% | 330B | |
+3.17% | 286B | |
+13.45% | 234B | |
+4.77% | 199B | |
-10.35% | 196B | |
-5.34% | 148B | |
-10.72% | 145B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Transcript : Johnson & Johnson, Q1 2024 Earnings Call, Apr 16, 2024